Logo image of ALMDP.PA

MEDESIS PHARMA SA (ALMDP.PA) Stock Price, Quote, News and Overview

EPA:ALMDP - Euronext Paris - Matif - FR0010844464 - Common Stock - Currency: EUR

0.381  -0.01 (-2.31%)

ALMDP.PA Quote, Performance and Key Statistics

MEDESIS PHARMA SA

EPA:ALMDP (3/7/2025, 7:00:00 PM)

0.381

-0.01 (-2.31%)

Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
Statistics
52 Week High2.4
52 Week Low0.3
Market Cap1.93M
Shares5.06M
Float4.21M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO02-12 2021-02-12


ALMDP.PA short term performance overview.The bars show the price performance of ALMDP.PA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20 -30 -40

ALMDP.PA long term performance overview.The bars show the price performance of ALMDP.PA in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of ALMDP.PA is 0.381 EUR. In the past month the price decreased by -9.5%. In the past year, price decreased by -68.51%.

MEDESIS PHARMA SA / ALMDP Daily stock chart

About ALMDP.PA

Company Profile

ALMDP logo image Medesis Pharma SA operates as a clinical development stage biopharmaceutical company, which engages in the research and development of orally administered molecule drugs. The company is headquartered in Baillargues, Occitanie. The company went IPO on 2021-02-12. The firm is engaged through its drug delivery technology Aonys in the development of orally administered molecule drug candidates to expand their therapeutic usefulness to address unmet medical needs. Its technology is also being used for collaborative research programs focused on oncology (customized cancer treatment) and radiotherapy (protection of healthy tissue). The Company’s two drug candidates for treating people contaminated following a civil or military nuclear accident are Plutonium decorporation and Cesium decorporation.

Company Info

MEDESIS PHARMA SA

L'Oree des Mas Avenue du Golf, Montpellier

Baillargues OCCITANIE FR

Employees: 10

Company Website: https://www.medesispharma.com/

Investor Relations: http://www.medesispharma.com/ipo/

Phone: 33467030396

MEDESIS PHARMA SA / ALMDP.PA FAQ

What is the stock price of MEDESIS PHARMA SA today?

The current stock price of ALMDP.PA is 0.381 EUR. The price decreased by -2.31% in the last trading session.


What is the ticker symbol for MEDESIS PHARMA SA stock?

The exchange symbol of MEDESIS PHARMA SA is ALMDP and it is listed on the Euronext Paris - Matif exchange.


On which exchange is ALMDP.PA stock listed?

ALMDP.PA stock is listed on the Euronext Paris - Matif exchange.


What is the price forecast or stock price prediction for MEDESIS PHARMA SA stock?

7 analysts have analysed ALMDP.PA and the average price target is 0.82 EUR. This implies a price increase of 114.17% is expected in the next year compared to the current price of 0.381. Check the MEDESIS PHARMA SA stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is MEDESIS PHARMA SA worth?

MEDESIS PHARMA SA (ALMDP.PA) has a market capitalization of 1.93M EUR. This makes ALMDP.PA a Nano Cap stock.


How many employees does MEDESIS PHARMA SA have?

MEDESIS PHARMA SA (ALMDP.PA) currently has 10 employees.


What are the support and resistance levels for MEDESIS PHARMA SA (ALMDP.PA) stock?

MEDESIS PHARMA SA (ALMDP.PA) has a support level at 0.38 and a resistance level at 0.41. Check the full technical report for a detailed analysis of ALMDP.PA support and resistance levels.


Should I buy MEDESIS PHARMA SA (ALMDP.PA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does MEDESIS PHARMA SA (ALMDP.PA) stock pay dividends?

ALMDP.PA does not pay a dividend.


ALMDP.PA Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to ALMDP.PA. When comparing the yearly performance of all stocks, ALMDP.PA is a bad performer in the overall market: 96.6% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

ALMDP.PA Financial Highlights


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A

ALMDP.PA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 40% to ALMDP.PA. The Buy consensus is the average rating of analysts ratings from 7 analysts.


Ownership
Inst OwnersN/A
Ins Owners11.57%
Short Float %N/A
Short RatioN/A
Analysts
Analysts40
Price Target0.82 (115.22%)
EPS Next YN/A
Revenue Next YearN/A